Gene · 7172
Papers3,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Comprehensive Literature Review on Managing Systemic Lupus Erythematosus: Addressing Cardiovascular Disease Risk in Females and Its Autoimmune Disease Associations. | Cureus | 2023 | 37727166 | PubTator, text mining | PubMed |
| Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update. | Ther Drug Monit | 2023 | 37726872 | PubTator, text mining | PubMed |
| Cytomegalovirus Pneumonia in Inflammatory Bowel Disease: Literature Review and Clinical Recommendations. | Infect Drug Resist | 2023 | 37724090 | PubTator, text mining | PubMed |
| Perineal hernia as a sequela of anal reconstruction surgeries in perianal Crohn's disease. | Radiol Case Rep | 2023 | 37691760 | PubTator, text mining | PubMed |
| Population Pharmacogenomics in Croatia: Evaluating the PGx Allele Frequency and the Impact of Treatment Efficiency. | Int J Mol Sci | 2023 | 37686303 | PubTator, text mining | PubMed |
| Precision Medicine in Inflammatory Bowel Disease. | Diagnostics (Basel) | 2023 | 37685335 | PubTator, text mining | PubMed |
| Sertoli cell-enriched proteins in mouse and human testicular interstitial fluid. | PLoS One | 2023 | 37656709 | PubTator, text mining | PubMed |
| Autoimmune hepatitis and overlap syndrome among Alaska Native people: Prevalence, clinical characteristics, and remission. | JGH Open | 2023 | 37649864 | PubTator, text mining | PubMed |
| Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States. | Front Pharmacol | 2023 | 37645439 | PubTator, text mining | PubMed |
| Development of innovative methodology for determination of 6-thioguanine in whole blood erythrocytes by HPLC-PDA-based technique for medical diagnostics purposes. | Sci Rep | 2023 | 37644112 | PubTator, text mining | PubMed |
| Preemptive TPMT Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for Autoimmune Diseases. | J Pers Med | 2023 | 37623459 | PubTator, text mining | PubMed |
| Commensal bacteria promote azathioprine therapy failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailability. | Cell Rep Med | 2023 | 37586320 | PubTator, text mining | PubMed |
| Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy. | Cancers (Basel) | 2023 | 37568739 | PubTator, text mining | PubMed |
| Genetic variations in idiopathic pulmonary fibrosis and patient response to pirfenidone. | Heliyon | 2023 | 37560683 | PubTator, text mining | PubMed |
| The c.415C>T polymorphism in NUDT15 is more frequent than the polymorphisms in TPMT in Chilean patients who use thiopurine drugs. | Pharmacogenet Genomics | 2023 | 37556121 | PubTator, text mining | PubMed |
| Assessing heterogeneity of treatment effect in multiple sclerosis trials. | Mult Scler | 2023 | 37555493 | PubTator, text mining | PubMed |
| Impact of Mercaptopurine Metabolites on Disease Outcome in the AIEOP-BFM ALL 2009 Protocol for Acute Lymphoblastic Leukemia. | Clin Pharmacol Ther | 2023 | 37550838 | PubTator, text mining | PubMed |
| Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study. | World J Gastroenterol | 2023 | 37545640 | PubTator, text mining | PubMed |
| Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. | Cell | 2023 | 37541199 | PubTator, text mining | PubMed |
| At-Risk Genomic Findings for Pediatric-Onset Disorders From Genome Sequencing vs Medically Actionable Gene Panel in Proactive Screening of Newborns and Children. | JAMA Netw Open | 2023 | 37523181 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7172/papers?page=14